Live feed12:49:56·43dINSIDERFilingChief Development Officer Davis Matthew W. was granted 50,000 shares, increasing direct ownership by 100% to 100,000 units (SEC Form 4)AQST· Aquestive Therapeutics Inc.Health CareOriginal source